[ Price : $8.95]
Biogen executives attempt to reassure investors Tuesday that its experimental anti-tau Alzheimer's disease therapy remains a promi...[ Price : $8.95]
Neurelis petitions FDA to ensure that any generic version of diazepam nasal spray is no less safe and effective than its Valtoco f...[ Price : $8.95]
House Energy and Commerce Committee ranking member Frank Pallone asks the Government Accountability Office to analyze how FDA paid...[ Price : $8.95]
A group of academic and public health experts urges FDA to embrace greater transparency, scientific independence and regulatory co...[ Price : $8.95]
FDA converts the accelerated approval of Eli Lilly's Retevmo (selpercatinib) into a traditional approval for treating adult and pe...[ Price : $8.95]
FDA finalizes updated guidance for industry outlining current recommendations for demonstrating bioequivalence of generic topical ...[ Price : $8.95]
The House Energy and Commerce Subcommittee on Health plans a hearing 7/15 to examine how FDA can help strengthen U.S. leadership i...[ Price : $8.95]
DTC Perspectives CEO Bob Ehrlich warns that an upcoming FDA proposal to eliminate the adequate provision standard could amount to ...